Skip to main content

PDAPP transgenic amyloid model (APP V717F Indiana)

Progressive appearance of AD-type neuropathology: thioflavin S-positive extracellular Aβ deposits, neuritic plaques, synaptic loss, astrogliosis, and microgliosis; the V717F (Indiana) mutation increases the Aβ42/Aβ40 ratio.

Experimental animals

Age
18 months of age
Tissue
brain

Model identity

Model name
PDAPP transgenic amyloid model (APP V717F Indiana)
Species
mouse
Taxonomy ID
10090
Genetic background
The original PDAPP founder population used a Swiss Webster×B6D2F1 (C57BL/6×DBA/2) mixed genetic background.
Genotype / zygosity
High expression of human APP V717F (Indiana) mutation

Biological characteristics

Research questions
Plaque formation and progression in the first amyloid model pedigree; pathological study driven by Aβ42 ratio
Limitations
The literature reference model does not represent what the company actually possesses, supplies, or performs quality control on; the transgenic overexpression paradigm and the full-spectrum pathology of human AD exhibit species and mechanistic differences;

References

  1. PMID:7845465; DOI:10.1038/373523a0; Nature 1995 · DOI: 10.1038/373523a0
  2. PMID:37887303; DOI:10.3390/cells12202459; PMC10605533; Cells 2023 (review of AD mammalian models) · DOI: 10.3390/cells12202459
  3. NCBI Taxonomy database record 10090: Mus musculus (house mouse), species rank. · https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=10090
  4. Chen G, Chen KS, Kobayashi D, et al. Active β-Amyloid Immunization Restores Spatial Learning in PDAPP Mice Displaying Very Low Levels of β-Amyloid. J Neurosci. 2007;27(10):2654–2662. DOI:10.1523/JNEUROSCI.3710-06.2007; PMID:17344403. Materials and Methods, Subjects: PDAPP founder background. · DOI: 10.1523/JNEUROSCI.3710-06.2007